Krilogy Financial’s Achillion Pharmaceuticals ACHN Stock Holding History

Krilogy Financial’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-600	Closed	-$2K	–	790
2018 Q3	$2K	Buy	+600	New	+$1.79K	﹤0.01%	759
2018 Q2	–	Sell	-600	Closed	-$2K	–	713
2018 Q1	$2K	Hold	600	–	–	﹤0.01%	714
2017 Q4	$2K	Hold	600	–	–	﹤0.01%	715
2017 Q3	$3K	Hold	600	–	–	﹤0.01%	717
2017 Q2	$3K	Hold	600	–	–	﹤0.01%	651
2017 Q1	$2K	Hold	600	–	–	﹤0.01%	664
2016 Q4	$2K	Hold	600	–	–	﹤0.01%	664
2016 Q3	$5K	Hold	600	–	–	﹤0.01%	608
2016 Q2	$5K	Hold	600	–	–	﹤0.01%	613
2016 Q1	$5K	Hold	600	–	–	﹤0.01%	544
2015 Q4	$6K	Hold	600	–	–	0.01%	306
2015 Q3	$4K	Buy	+600	New	+$4.89K	﹤0.01%	500

Other funds holding ACHN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Krilogy Financial's ACHN Position: Q4 2018 in Review

Krilogy Financial sold out of Achillion Pharmaceuticals (ACHN) in Q4 2018, closing a stake of 600 shares — an estimated $2K sold.

Krilogy Financial first reported a position in ACHN in Q3 2015 and held it in 12 quarters. The position peaked at $6K in Q4 2015. 121 funds tracked by Wall St. Rank hold ACHN as of Q4 2018.

Krilogy Financial reported no remaining Achillion Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Krilogy Financial sold 600 Achillion Pharmaceuticals shares in Q4 2018, an estimated $2K.
Krilogy Financial first reported a position in Achillion Pharmaceuticals in Q3 2015 and held it in 12 quarters.
Krilogy Financial's Achillion Pharmaceuticals position peaked at $6K in Q4 2015.
121 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.